AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Jacobson, JM Feinman, L Liebes, L Ostrow, N Koslowski, V Tobia, A Cabana, BE Lee, DH Spritzler, J Prince, AM
Citation: Jm. Jacobson et al., Pharmacokinetics, safety, and antiviral effects of hypericin, a derivativeof St. John's Wort plant, in patients with chronic hepatitis C virus infection, ANTIM AG CH, 45(2), 2001, pp. 517-524

Authors: Ng, B Kramer, E Liebes, L Wasserheit, C Hochster, H Blank, E Ceriani, R Furmanski, P
Citation: B. Ng et al., Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts, CANCER RES, 61(7), 2001, pp. 2996-3001

Authors: Liebes, L Conaway, CC Hochster, H Mendoza, S Hecht, SS Crowell, J Chung, FL
Citation: L. Liebes et al., High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: Application to studies with 2-phenethyl isothiocyanate, ANALYT BIOC, 291(2), 2001, pp. 279-289

Authors: Prince, AM Pascual, D Meruelo, D Liebes, L Mazur, Y Dubovi, E Mandel, M Lavie, G
Citation: Am. Prince et al., Strategies for evaluation of enveloped virus inactivation in red cell concentrates using hypericin, PHOTOCHEM P, 71(2), 2000, pp. 188-195

Authors: Hochster, H Wadler, S Runowicz, C Liebes, L Cohen, H Wallach, R Sorich, J Taubes, B Speyer, J
Citation: H. Hochster et al., Activity and pharmacodynamics of 21-day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy, J CL ONCOL, 17(8), 1999, pp. 2553-2561

Authors: Sparano, JA Speyer, J Gradishar, WJ Liebes, L Sridhara, R Mendoza, S Fry, D Egorin, MJ
Citation: Ja. Sparano et al., Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer, J CL ONCOL, 17(3), 1999, pp. 880-886

Authors: Conaway, CC Jiao, D Kohri, T Liebes, L Chung, FL
Citation: Cc. Conaway et al., Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats, DRUG META D, 27(1), 1999, pp. 13-20

Authors: Gulick, RM McAuliffe, V Holden-Wiltse, J Crumpacker, C Liebes, L Stein, DS Meehan, P Hussey, S Forcht, J Valentine, FT
Citation: Rm. Gulick et al., Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults - AIDS clinical trials group protocols 150 and 258, ANN INT MED, 130(6), 1999, pp. 510-514
Risultati: 1-8 |